Form 4: Aura Biosciences CFO Acquires Shares and Warrants in Public Offering, Sells Shares for Tax Obligations

Anthony S. Gibney, CFO of Aura Biosciences, purchased shares and warrants in a public offering and sold shares to cover tax obligations.

Summary

• On May 16, 2025, Anthony S. Gibney, the CFO of Aura Biosciences, purchased 50,000 shares of common stock and warrants to purchase 12,500 shares at $4.90 per share in an underwritten public offering.
• Gibney also sold 1,519 shares at $5.15 per share to cover tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Gibney directly owns 56,933 shares of Aura Biosciences common stock and warrants for 12,500 shares.

Sentiment

Score: 7

Explanation: The CFO's purchase of shares and warrants is a positive signal, indicating confidence in the company. The sale of shares for tax obligations is a neutral event.

Positives

• The CFO's purchase of shares and warrants in the public offering demonstrates confidence in the company's future.

Negatives

• The sale of shares to cover tax obligations, while routine, slightly reduces the CFO's holdings.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• The CFO's stock purchase could positively influence investor sentiment.

Key Dates

Keywords

Aura Biosciences, CFO, Anthony S. Gibney, Form 4, Share Purchase, Warrants, Public Offering, Tax Obligations, Insider Trading